Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 188,978 | 207,291 | 124,169 | 121,136 | 142,350 |
| TOTAL | $202,549 | $222,122 | $133,999 | $129,633 | $150,184 |
| Non-Current Assets | |||||
| PPE Net | 21,135 | 21,364 | 21,604 | 21,854 | 22,077 |
| Intangibles | 69 | 82 | 115 | 176 | 268 |
| TOTAL | $21,204 | $21,446 | $21,719 | $22,030 | $22,345 |
| Total Assets | $223,753 | $243,568 | $155,718 | $151,663 | $172,529 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 52,244 | 52,552 | 9,603 | 10,573 | 9,492 |
| Accrued Expenses | 4,493 | 1,814 | 2,025 | 3,237 | 7,531 |
| Other current liabilities | N/A | 228 | 65,493 | 385 | 391 |
| TOTAL | $57,034 | $54,594 | $77,121 | $14,195 | $17,414 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 80 | 0 | 0 | 0 | 0 |
| TOTAL | $80 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $57,114 | $54,594 | $77,121 | $14,195 | $17,414 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,110 | 47,976 | 47,976 | 43,225 | 42,174 |
| Common Shares | 48 | 48 | 43 | 42 | 42 |
| Retained earnings | -377,514 | -349,571 | -355,726 | -380,769 | -359,850 |
| TOTAL | $166,639 | $188,974 | $78,597 | $137,468 | $155,115 |
| Total Liabilities And Equity | $223,753 | $243,568 | $155,718 | $151,663 | $172,529 |